Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP936034.RAW5YxqxpAX243oH1oMdXWWsyYbcNjza8IC-7ptqx48zs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP936034.RAW5YxqxpAX243oH1oMdXWWsyYbcNjza8IC-7ptqx48zs130_assertion type Assertion NP936034.RAW5YxqxpAX243oH1oMdXWWsyYbcNjza8IC-7ptqx48zs130_head.
- NP936034.RAW5YxqxpAX243oH1oMdXWWsyYbcNjza8IC-7ptqx48zs130_assertion description "[We recently reported that the interleukin (IL)-28B major genotype is a predictor of early suppression of the hepatitis C virus (HCV) at 12 weeks in response to pegylated interferon (PEG-IFN) plus ribavirin (RBV) therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP936034.RAW5YxqxpAX243oH1oMdXWWsyYbcNjza8IC-7ptqx48zs130_provenance.
- NP936034.RAW5YxqxpAX243oH1oMdXWWsyYbcNjza8IC-7ptqx48zs130_assertion evidence source_evidence_literature NP936034.RAW5YxqxpAX243oH1oMdXWWsyYbcNjza8IC-7ptqx48zs130_provenance.
- NP936034.RAW5YxqxpAX243oH1oMdXWWsyYbcNjza8IC-7ptqx48zs130_assertion SIO_000772 22052088 NP936034.RAW5YxqxpAX243oH1oMdXWWsyYbcNjza8IC-7ptqx48zs130_provenance.
- NP936034.RAW5YxqxpAX243oH1oMdXWWsyYbcNjza8IC-7ptqx48zs130_assertion wasDerivedFrom befree-2016 NP936034.RAW5YxqxpAX243oH1oMdXWWsyYbcNjza8IC-7ptqx48zs130_provenance.
- NP936034.RAW5YxqxpAX243oH1oMdXWWsyYbcNjza8IC-7ptqx48zs130_assertion wasGeneratedBy ECO_0000203 NP936034.RAW5YxqxpAX243oH1oMdXWWsyYbcNjza8IC-7ptqx48zs130_provenance.